Your browser doesn't support javascript.
loading
Optimizing bone morphogenic protein 4-mediated human embryonic stem cell differentiation into trophoblast-like cells using fibroblast growth factor 2 and transforming growth factor-ß/activin/nodal signalling inhibition.
Koel, Mariann; Võsa, Urmo; Krjutskov, Kaarel; Einarsdottir, Elisabet; Kere, Juha; Tapanainen, Juha; Katayama, Shintaro; Ingerpuu, Sulev; Jaks, Viljar; Stenman, Ulf-Hakan; Lundin, Karolina; Tuuri, Timo; Salumets, Andres.
Afiliación
  • Koel M; Competence Centre on Health Technologies, Tartu, Estonia; Department of Cell Biology, Institute of Molecular and Cell Biology, University of Tartu, Tartu, Estonia; Department of Biosciences and Nutrition, and Centre for Innovative Medicine, Karolinska Institutet, Huddinge, Sweden. Electronic address
  • Võsa U; Estonian Genome Center, University of Tartu, Tartu, Estonia.
  • Krjutskov K; Competence Centre on Health Technologies, Tartu, Estonia; Department of Biosciences and Nutrition, and Centre for Innovative Medicine, Karolinska Institutet, Huddinge, Sweden; Molecular Neurology Research Program, University of Helsinki and Folkhälsan Institute of Genetics, Helsinki, Finland.
  • Einarsdottir E; Department of Biosciences and Nutrition, and Centre for Innovative Medicine, Karolinska Institutet, Huddinge, Sweden; Molecular Neurology Research Program, University of Helsinki and Folkhälsan Institute of Genetics, Helsinki, Finland.
  • Kere J; Department of Biosciences and Nutrition, and Centre for Innovative Medicine, Karolinska Institutet, Huddinge, Sweden; Molecular Neurology Research Program, University of Helsinki and Folkhälsan Institute of Genetics, Helsinki, Finland.
  • Tapanainen J; Department of Obstetrics and Gynecology, University of Helsinki and Helsinki University Hospital, Helsinki, Finland.
  • Katayama S; Department of Biosciences and Nutrition, and Centre for Innovative Medicine, Karolinska Institutet, Huddinge, Sweden.
  • Ingerpuu S; Department of Cell Biology, Institute of Molecular and Cell Biology, University of Tartu, Tartu, Estonia.
  • Jaks V; Department of Cell Biology, Institute of Molecular and Cell Biology, University of Tartu, Tartu, Estonia; Department of Biosciences, Karolinska Institutet, Huddinge, Sweden.
  • Stenman UH; Department of Clinical Chemistry, University of Helsinki, Helsinki, Finland.
  • Lundin K; Department of Obstetrics and Gynecology, University of Helsinki and Helsinki University Hospital, Helsinki, Finland.
  • Tuuri T; Department of Obstetrics and Gynecology, University of Helsinki and Helsinki University Hospital, Helsinki, Finland.
  • Salumets A; Competence Centre on Health Technologies, Tartu, Estonia; Department of Obstetrics and Gynecology, University of Helsinki and Helsinki University Hospital, Helsinki, Finland; Department of Obstetrics and Gynaecology, University of Tartu, Tartu, Estonia; Institute of Biomedicine and Translational Med
Reprod Biomed Online ; 35(3): 253-263, 2017 Sep.
Article en En | MEDLINE | ID: mdl-28647356
Asunto(s)
Palabras clave
Texto completo
Añadir a Mi BVS
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Trofoblastos / Diferenciación Celular / Proteína Morfogenética Ósea 4 / Células Madre Embrionarias Humanas Tipo de estudio: Prognostic_studies Límite: Humans Idioma: En Revista: Reprod Biomed Online Asunto de la revista: MEDICINA REPRODUTIVA Año: 2017 Tipo del documento: Article Pais de publicación: Países Bajos
Texto completo
Añadir a Mi BVS
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Trofoblastos / Diferenciación Celular / Proteína Morfogenética Ósea 4 / Células Madre Embrionarias Humanas Tipo de estudio: Prognostic_studies Límite: Humans Idioma: En Revista: Reprod Biomed Online Asunto de la revista: MEDICINA REPRODUTIVA Año: 2017 Tipo del documento: Article Pais de publicación: Países Bajos